Owner Investor / Financier Operator Developer Technology licensor Technology / equipment supplier
Ercros is a Spain-based chemical group headquartered in Barcelona. With a heritage that brings together historic companies such as Cros and Erkimia, it operates multiple production sites across Spain and serves international markets. The company focuses on three main areas: chlorine-alkali and derivatives, intermediate chemicals, and pharmaceuticals.
Its portfolio spans caustic soda, chlorine and related derivatives, sodium hypochlorite and chlorate, and chlorinated isocyanurates for water treatment; formaldehyde, paraformaldehyde, and resins for industrial applications; and active pharmaceutical ingredients (APIs) and intermediates. Ercros’ products supply sectors including water treatment, construction materials, coatings, plastics, and healthcare. The company emphasizes integrated manufacturing along the chlorine value chain and the conversion of basic chemicals into higher value-added derivatives and specialty products.
chemXplore tracks 11 projects involving Ercros, of which 4 are active.
Besides these 4, the record holds 7 completed projects.
Closest to start-up first.
The 7 that are completed, on hold or cancelled are in the record. See all 11 in chemXplore →
Net loss €3.9m in H1 2026 despite €22.7m adjusted EBITDA; liquidity €75m; delisting approved with Bondalti Iberica tender at €3.505/share.
Public EcoVerda financing will fund electric boiler, biomass steam, waste-heat recovery and hydrogen optimisation to cut the complex's CO₂ emissions by 56%.
Q1: contribution €52m; adj. EBITDA −€1m; liquidity €45m. Weak demand, high energy costs, non‑EU competition. Bondalti bid 77.23% accepted. New board aims to delist, restore profitability, integrate
Mónica Viloria will serve a four‑year term as president, aiming to strengthen the council as a shippers' forum on transport, logistics and customs and boost business competitiveness.
Ranks in the 98th percentile; environment & ethics 91, labour & human rights 90. Advanced management, many KPIs provided; 100/100 for endorsements, measures and certifications
Shareholders selling now miss future synergies. Bondalti's bid may hinder Ercros' 3D Plan and strategic investments. Energy price risks persist amid geopolitical tensions.
Weak demand, high energy costs, and competition impact results. Cost reduction plan on track. Financial debt reduced. Takeover bid rejected. Demand recovery expected in late 2026.
The board cites strategic misalignment, potential debt increase, and shareholder opposition as reasons for rejecting the unsolicited bid.
active all projects
